Yanxia Zhao

Area of research

Cancer Research · Oncology

Research interest

Research focused on Coronavirus disease 2019 (COVID-19) and Losartan, with related work in Coronavirus, Oncology, Claudin. Notable publications include 'The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019', 'Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma', and '651P Phase I study of XNW27011, a novel claudin 18.2 ADC, in patients with locally advanced and/or metastatic solid tumors'.

h-index

—

citations

676

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

651P Phase I study of XNW27011, a novel claudin 18.2 ADC, in patients with locally advanced and/or metastatic solid tumors

Annals of Oncology 2024cited by 7position: middledoi

The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019

EMBO Molecular Medicine 2020cited by 410position: middledoi

Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma

Proceedings of the National Academy of Sciences 2019cited by 259position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Cancer Research · Oncology →